SSR Mining’s U.S. Pivot: A Clear Path to Re-rating and Cash Return

Hook + thesis

SSR Mining (SSRM) has quietly repositioned itself into a cleaner, Americas-focused miner with meaningful balance-sheet optionality. The announced sale of its 80% stake in the Çöpler (Copler) mine in Turkey for $1.5 billion, combined with a newly authorized 10% share buyback and a near-zero net-debt profile, creates a near-term path for capital returns and a longer-term rerating of the stock.

We view SSRM as an actionable long. The company trades at an enterprise value of roughly $5.36 billion and an attractive EV/EBITDA of 5.9x, while generating free cash flow ($378.0 million most recently). Management’s decision to cut emerging market exposure and redeploy proceeds to buybacks and organic Americas growth should materially lower perceived execution risk and compress the discount applied by investors. Our trade: enter at $28.70, stop at $25.00, target $36.50 over a mid term (45 trading days) horizon.

Business snapshot - why the market should care

SSR Mining is a diversified precious-metals producer operating in the USA, Canada, Argentina and Turkiye, with key assets that include Marigold (Nevada), Seabee (Saskatchewan), Puna (Argentina) and the former Copler interest in Turkey. The corporate story in 2026 is one of derisking and refocus: exiting a troubled overseas asset, strengthening liquidity and concentrating capital on North and South American operations.

Why that matters: investors typically pay higher multiples for geographically simpler portfolios with lower political and operational risk. SSRM’s move reduces emerging-market exposure and should increase the multiple investors are willing to assign to its cash flow stream.

What the numbers say

Two facts jump out from the numbers. First, SSRM is cash-rich and essentially debt-free: the company shows more than $2.3 billion of cash and an almost negligible debt-to-equity ratio (0.02). That gives management option value - they can repurchase stock, accelerate growth projects in the Americas, or pay down any future liabilities without threatening the balance sheet.

Second, valuation looks reasonable for a producer with stable free cash flow. The EV/EBITDA of 5.9x is materially below many diversified mining peers in bear-to-normal cycles, and FCF of $378 million implies the company can fund buybacks and sustain capital projects without leaning on markets.

Recent corporate actions - why they matter

• Sale of 80% Copler interest for $1.5 billion - announced and trading reaction in March/April 2026: management’s decision to sell a troubled, higher-risk asset crystallizes value and reduces geopolitical execution risk. The deal is expected to close pending regulatory approvals in Q3 2026.
• 10% share buyback authorization - a direct way to use proceeds to return capital and lift per-share metrics.
• Strong free cash flow and liquidity - the company reported strong Q1 free cash flow of $211 million and recent free cash flow of $378 million, supporting buybacks and sustaining operations.

Catalysts (what could drive the stock higher)

• Closing of the Copler sale and redeployment of proceeds (expected Q3 2026) - clarity and improved cash per share could trigger re-rating.
• Aggressive execution of the 10% buyback program - buybacks would reduce float and lift EPS and cash-return metrics.
• Better-than-expected operational performance at Americas assets (Marigold, Seabee, Puna) - outperformance on production or cost reduction will show the company’s core portfolio is durable.
• Higher gold or silver prices - SSRM is levered to precious metals; price appreciation would flow straight to margins and cash flow.
• Analyst re-ratings and multiple expansion as investors digest the reduced-country risk profile.

Risks and counterarguments

No investment is without risk; here are the principal arguments that could stop this trade from working, followed by a counterargument to each to keep the assessment balanced.

• Deal risk - regulatory or timing delays: The $1.5 billion Copler sale requires approvals and is expected to close in Q3 2026. Delays or a blocked transaction would keep the balance sheet in flux and could re-introduce the market’s discount for geopolitical exposure. Counter: even if the sale is delayed, SSRM already shows strong liquidity and no material debt, which limits downside from temporary uncertainty.
• Gold/silver price weakness: Precious-metal prices remain the biggest macro variable. A meaningful drop would reduce cash flow and delay share buybacks. Counter: current guidance (2026 production 450k-535k gold-equivalent ounces) implies robust output that supports cash flow across a range of metal prices; plus de-risking reduces production volatility.
• Operational headwinds at core mines: Unexpected cost inflation, geotechnical issues, or lower grades at Marigold/Seabee/Puna would hit margins. Counter: SSRM’s portfolio includes multiple producing assets across jurisdictions, which helps diversify single-mine risk.
• Share-count and allocation risk: Management may favor buybacks over higher-return growth projects, or fail to opportunistically allocate the Copler proceeds. Counter: management has signaled belief that the stock is undervalued and authorized a buyback; returning capital while preserving project optionality can be value accretive if executed prudently.
• Market already priced in improvement: The stock rallied sharply on the sale and buyback news in March-April 2026; some upside may already be baked in. Counter: even after the rally the company trades at a low EV/EBITDA and has notable FCF yield versus many peers, leaving room for multiple expansion if execution continues.

Technicals and sentiment

On the technical side SSRM sits around $28.70 with a 52-week high of $36.52 and a low of $11.70, leaving clear upside to the recent peak. Momentum indicators are neutral-to-mildly constructive: RSI ~47 and MACD showing a modest bullish state. Short interest is not extreme (several million shares), and recent short-volume activity suggests elevated trading interest but not a one-sided squeeze setup.

Trade plan (actionable)

Thesis: The Copler sale, the buyback authorization and a clean balance sheet materially reduce risk and create an earnings/cash-flow growth path that the market should reward. We expect the stock to re-rate toward prior highs as headline risk drops and buybacks commence.

Specific trade:

• Direction: Long
• Entry price: $28.70
• Target price: $36.50 (near prior 52-week high)
• Stop loss: $25.00
• Horizon: mid term (45 trading days) - we expect the primary re-rating catalysts (deal clarity and early buyback activity) to play out within this window. If the trade reaches its target, consider re-evaluating for a longer hold into the close of Q3 2026.

Rationale: Entry is near the current trading level and under the short-term moving averages, giving a defined risk at $25.00. The target is set near the 52-week high where momentum and analyst attention previously clustered. The stop is wide enough to avoid noise but tight enough to control risk-to-reward.

What would change my mind

I will downgrade this trade thesis if one of the following occurs: the Copler sale is materially renegotiated at a lower price, meaningfully weaker-than-guidance production/outlook from Americas assets is reported, or if management signals that proceeds will be used for lower-return projects rather than buybacks and shareholder returns. Conversely, if buybacks accelerate or management provides clear, specific allocation plans and Q3 closing occurs on schedule, I would increase conviction and extend the horizon to a long term (180 trading days) hold.

Conclusion

SSR Mining’s recent strategic pivot is a classic de-risk-and-return-to-shareholders story. The balance sheet is strong, free cash flow is real and large enough to support buybacks without compromising operations. At an EV/EBITDA of about 5.9x and with near-term catalysts that can reduce the company’s risk premium, SSRM presents an attractive medium-term long opportunity with clearly defined risk controls. Enter at $28.70, protect downside at $25.00, and aim for $36.50 over roughly 45 trading days while monitoring deal progress and operational execution closely.

Key points

• Copler 80% stake sale for $1.5B (expected close Q3 2026) materially reduces geopolitical risk.
• Company holds roughly $2.32B in cash and essentially zero net debt; free cash flow of $378M supports buybacks.
• Valuation at EV/EBITDA ~5.9x looks cheap for a diversified Americas-focused producer with stable cash generation.
• Trade setup: Long at $28.70, stop $25.00, target $36.50, mid term (45 trading days).